Workflow
Accelerate Diagnostics(AXDX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Accelerate Diagnostics Reports Second Quarter 2024 Financial Results TUCSON, Ariz., August 8, 2024 -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2024. During the quarter we completed our pre-clinical trial demonstrating strong analytical performance of our WAVE System and GramNegative Positive Blood Culture (PBC) assay. We are pleased to announce our pre-clinical trial was a success." commented Jack Phillips, President and ...